化合物SKLB-163 T26193
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 1255099-06-9 | ¥2,920.00 | 询底价 |
10 mg | 1255099-06-9 | ¥4,320.00 | 询底价 |
50 mg | 1255099-06-9 | ¥9,330.00 | 询底价 |
100 mg | 1255099-06-9 | ¥12,500.00 | 询底价 |
25 mg | 1255099-06-9 | ¥6,880.00 | 询底价 |
1 mL | 1255099-06-9 | ¥2,970.00 | 询底价 |
500 mg | 1255099-06-9 | ¥25,200.00 | 询底价 |
1 mg | 1255099-06-9 | ¥1,170.00 | 询底价 |
Product Introduction
Bioactivity
英文名: SKLB-163
描述: SKLB-163 通过下调 RhoGDI、激活 JNK-1 信号通路和 caspase-3 以及减少磷酸化 Akt 和 p44/42 MAPK 发挥作用。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55 mg/ml (135.49 mM)
关键字: SKLB-163 | SKLB 163
相关产品: CMPD1 | Antimicrobial agent-21 | PF-06260933 | 3β-Methoxy-2,3-dihydrowithaferin A | PF-3644022 | MAP4K4-IN-3 | Scandoside | MBP MAPK Substrate acetate | TC ASK 10 | Quercetin 3-O-(6''-galloyl)-β-D-galactopyranoside
相关库: Anti-Neurodegenerative Disease Compound Library | Cell Cycle Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Ovarian Cancer Compound Library | Kinase Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Anti-Obesity Compound Library | Anti-Pancreatic Cancer Compound Library | Reprogramming Compound Library | Stem Cell Differentiation Compound Library
化合物SKLB-163 T26193信息由TargetMol中国为您提供,如您想了解更多关于化合物SKLB-163 T26193报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途